首页> 美国卫生研究院文献>Biomedicines >Aptamers for Proteins Associated with Rheumatic Diseases: Progress Challenges and Prospects of Diagnostic and Therapeutic Applications
【2h】

Aptamers for Proteins Associated with Rheumatic Diseases: Progress Challenges and Prospects of Diagnostic and Therapeutic Applications

机译:与风湿病有关的蛋白质的适体:诊断和治疗应用的进步挑战和前景

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Nucleic acid aptamers capable of affine and specific binding to their molecular targets have now established themselves as a very promising alternative to monoclonal antibodies for diagnostic and therapeutic applications. Although the main focus in aptamers’ research and development for biomedicine is made on cardiovascular, infectious, and malignant diseases, the use of aptamers as therapeutic or diagnostic tools in the context of rheumatic diseases is no less important. In this review, we consider the main features of aptamers that make them valuable molecular tools for rheumatologists, and summarize the studies on the selection and application of aptamers for protein biomarkers associated with rheumatic diseases. We discuss the progress in the development of aptamer-based diagnostic assays and targeted therapeutics for rheumatic disorders, future prospects in the field, and issues that have yet to be addressed.
机译:能够与其分子靶标进行脱染和特异性结合的核酸适体现在已经成为诊断和治疗应用的单克隆抗体的非常有前途的替代方法。虽然在体育植物,传染病和恶性疾病上进行了适体的研究和开发的主要关注,但在风湿病的背景下使用适体作为治疗或诊断工具的使用不太重要。在这篇综述中,我们考虑适体的主要特征,使其成为风湿病学家的有价值的分子工具,并总结了对与风湿性疾病相关的蛋白质生物标志物的选择和应用的研究。我们讨论了素质基于型诊断测定和靶向治疗的流动性障碍,领域未来前景的进展,以及尚未解决的问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号